| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/19/1991 | CA2023521A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 02/19/1991 | CA2022865A1 Analogues of 8-d-homoarginine vasopressin |
| 02/19/1991 | CA1280379C Peptides and compositions |
| 02/19/1991 | CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii |
| 02/13/1991 | EP0412766A1 Peptide fragments of HIV |
| 02/13/1991 | EP0412762A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 02/13/1991 | EP0412542A2 Cyclic neurokinin antagonists |
| 02/13/1991 | EP0412508A1 Analogues of vasopressin, their preparation and pharmaceutical use |
| 02/13/1991 | EP0412115A1 Hybrid peptides and methods of their use |
| 02/13/1991 | CN1049166A Substitution analogues of magainin peptides |
| 02/12/1991 | CA2021880A1 Psycho-pharmacological peptides |
| 02/10/1991 | WO1991001996A1 Peptide fragments of hiv |
| 02/10/1991 | CA2064691A1 Peptide fragments of hiv |
| 02/08/1991 | CA2022394A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 02/07/1991 | WO1991001144A1 Labeled polypeptide derivatives |
| 02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 02/06/1991 | EP0411895A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 02/06/1991 | EP0411833A1 Fibrinogen receptor antagonists |
| 02/06/1991 | EP0411503A1 Process for identifying and synthesizing binding sites of interacting proteins |
| 02/06/1991 | EP0411334A1 Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain |
| 02/06/1991 | EP0411332A1 Antiviral peptides having a 2-oxoalkyl amino acid side chain |
| 02/06/1991 | EP0410989A1 Cyclic analogs of atrial natriuretic peptides |
| 02/05/1991 | US4990596 Synthetic peptide producing antibodies of enhanced binding to human LDH-C4 |
| 02/01/1991 | CA2022111A1 Imidazole compounds and their use as transglutaminase inhibitors |
| 01/30/1991 | EP0410767A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410713A1 Polypeptide inhibitor of viral replication |
| 01/30/1991 | EP0410541A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410540A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410539A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410537A1 Fibrinogen receptor antagonists |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410182A2 A new technique for rapid peptide coupling |
| 01/30/1991 | EP0410147A1 Modified VP1/P2A regions of rhinovirus systems |
| 01/30/1991 | EP0409962A1 Agent for inhibiting symmetrical proteins, in particular enzymes. |
| 01/29/1991 | CA2021953A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021952A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021951A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021950A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021949A1 Fibrinogen receptor antagonists |
| 01/29/1991 | CA2021948A1 Fibrinogen receptor antagonists |
| 01/26/1991 | WO1991001329A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | CA2063801A1 Polypeptide inhibitor of viral replication |
| 01/24/1991 | WO1991000869A1 Substitution analogues of magainin peptides |
| 01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
| 01/23/1991 | EP0409045A2 Pentapeptide antibiotics derived from dalbaheptides |
| 01/23/1991 | EP0408973A1 Antiherpes pentapeptides |
| 01/23/1991 | EP0408663A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
| 01/23/1991 | EP0387276A4 Method to produce immunodiagnostic reagents |
| 01/23/1991 | EP0243429B1 D-luciferin derivatives and their use |
| 01/22/1991 | US4987122 Peptide compounds and medical method of use thereof |
| 01/22/1991 | US4986988 Antitumor agents |
| 01/18/1991 | WO1991001331A1 Small cyclic platelet aggregation inhibitors |
| 01/18/1991 | CA2063557A1 Small cyclic platelet aggregation inhibitors |
| 01/17/1991 | DE4020211A1 New rhinoviral DNA with mutation(s) in protease 2A region - and corresponding oligo:nucleotide(s) and oligopeptide(s), useful in test systems and as therapeutic competitive inhibitors |
| 01/16/1991 | EP0408371A1 Hemoregulatory peptides |
| 01/16/1991 | EP0408301A1 DNA coding for a polypeptide signal sequence in vaccinia virus |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
| 01/16/1991 | EP0366777A4 Stimulation of chemotaxis by chemotactic peptides |
| 01/15/1991 | WO1991001333A1 Methods of treating or preventing autoimmune uveoretinitis in mammals |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | US4985406 Central nervous system disorders, dopaminergic pathways |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/12/1991 | WO1991000911A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2063389A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/10/1991 | WO1991000348A1 Modified vp1/p2a regions of the rhinoviral system |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/10/1991 | WO1990012807A3 Purified, highly specific antibodies against gene products including retinoblastoma and method |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0406931A2 New analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions |
| 01/09/1991 | EP0406428A1 Peptide derivatives and their use |
| 01/08/1991 | CA2535463A1 Octreotide-pamoate and its use in sustained release formulations of water soluble peptides |
| 01/08/1991 | CA2020650A1 Technique for rapid peptide coupling |
| 01/07/1991 | WO1991000736A1 Dynorphin analogs specific for kappa opioid receptors |
| 01/07/1991 | CA2063712A1 Dynorphin analogs specific for kappa opioid receptors |
| 01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
| 01/02/1991 | EP0405998A1 Antibiotic agents |
| 01/02/1991 | EP0405997A1 Antibiotic agent |
| 01/02/1991 | EP0405763A1 GRF peptides |
| 01/02/1991 | CA1278650C Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process |
| 01/01/1991 | US4981842 Antitumor peptides |
| 01/01/1991 | US4981782 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
| 12/31/1990 | CA2020129A1 Analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions |
| 12/31/1990 | CA2020063A1 Antibiotic agent |
| 12/27/1990 | WO1990015818A1 Synthetic peptides for use in thrombus detection |
| 12/27/1990 | WO1990015620A1 Platelet aggregation inhibitors |
| 12/27/1990 | WO1990015614A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
| 12/27/1990 | EP0403600A1 Deprotection of protected peptides |
| 12/27/1990 | CA2388770A1 Platelet aggregation inhibitors |
| 12/25/1990 | CA2019661A1 Modified vp1/p2a region of the rhinovirus system |
| 12/22/1990 | WO1990015872A1 Recombinant poxvirus and streptococcal m protein vaccine |
| 12/19/1990 | EP0403312A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 12/19/1990 | EP0403172A2 Purified enzyme and process therefor |
| 12/19/1990 | EP0402852A1 Irreversible bombesin antagonists |
| 12/16/1990 | WO1990015878A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 12/16/1990 | WO1990015819A1 Irreversible bombesin antagonists |
| 12/16/1990 | CA2034480A1 Irreversible bombesin antagonists |
| 12/13/1990 | WO1990015331A1 Diagnostic assay for alzheimer's disease |
| 12/13/1990 | WO1990015074A1 Methods for enhancing the rate of modification of metastable bonds |
| 12/13/1990 | WO1990015070A1 Very large scale immobilized peptide synthesis |